Cargando…
CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models
This protocol details the procedure for CRISPR-assisted insertion of epitopes (CRISPitope), a flexible approach for generating tumor cells expressing model CD8(+) T cell epitopes fused to endogenously encoded gene products of choice. CRISPitope-engineered tumor cells can be recognized by T cell rece...
Autores principales: | Effern, Maike, Glodde, Nicole, Bawden, Emma, Liebing, Jana, Hinze, Daniel, Tüting, Thomas, Gebhardt, Thomas, Hölzel, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755566/ https://www.ncbi.nlm.nih.gov/pubmed/35059651 http://dx.doi.org/10.1016/j.xpro.2021.101038 |
Ejemplares similares
-
From Tpex to Tex: a journey through CD8(+) T cell responses in cancer immunotherapy
por: Messmer, Julia M., et al.
Publicado: (2023) -
The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy
por: Ruotsalainen, Janne, et al.
Publicado: (2021) -
A stochastic model for immunotherapy of cancer
por: Baar, Martina, et al.
Publicado: (2016) -
Does NICE influence the adoption and uptake of generics in the UK?
por: Serra-Sastre, Victoria, et al.
Publicado: (2020) -
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
por: Martins Nascentes Melo, Luiza, et al.
Publicado: (2023)